Skip to main content
Figure 5 | BMC Complementary and Alternative Medicine

Figure 5

From: Prevention of allergic airway hyperresponsiveness and remodeling in mice by Astragaliradix Antiasthmatic decoction

Figure 5

AAD modulated the levels of cytokines in BALF of mice. The BALF was harvested at 48 h after the final OVA (or NS) challenge. Levels of IL-13 (A), TGF-β (B), IFN-γ (C), and IL-10 (D) in the supernatant of BALF were evaluated by ELISA. Data are presented as means ± SE for 8–10 mice per group. H + OVA: OVA challenged and treated with high dose AAD, L + OVA: OVA challenged and treated with low dose AAD. #p < 0.05 compared with NS. *P < 0.05 compared with OVA group. NS means not significant.

Back to article page